Checked.be
Active
BE 0825.151.779Public limited company
BIOXODES
Rue Santos - Dumont 1 ·6041 Charleroi, Belgium· 16 yrs active
Sector: NACE 72101
(72101)
Conclusion
The computed 12-month bankruptcy probability of BIOXODES is 0.3% (very low). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Key figures
| Active | 16 yrs |
| Board | 13 |
| Locations | 1 |
| Publications | 77 |
Bankruptcy probability (12 mo)
0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Lower-risk legal form
−Long track record
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2010 — 16 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
No administrative flags
Financial overview
Financials being processed
NBB has 10 filing(s) on record for this company — latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 16-07-2025 | 2025-00274086 |
| 31-12-2023 | volledig | 23-07-2024 | 2024-00271025 |
| 31-12-2022 | volledig | 14-07-2023 | 2023-00235430 |
| 31-12-2021 | volledig | 23-08-2022 | 2022-20305384 |
| 31-12-2020 | volledig | 13-07-2021 | 2021-34200330 |
| 31-12-2019 | volledig | 04-08-2020 | 2020-37700413 |
| 31-12-2018 | volledig | 25-06-2019 | 2019-21500537 |
| 31-12-2017 | volledig | 31-07-2018 | 2018-40100346 |
| 31-12-2016 | volledig | 08-08-2017 | 2017-41400415 |
| 31-12-2015 | volledig | 30-06-2016 | 2016-24900476 |
Directors & mandates
Current directors & mandates
-
Current02-10-2025 → present
-
Current05-10-2022 → present
2 events
- 08-11-2022 Appointed· Director
- 05-10-2022 Mandate renewed· Daily management
-
SAS CROUGHS R&D CONSULTINGLegal entityDirector· perm. rep.: Thérèse CroughsState Gazette act 21036646 (23-03-2021)Current15-12-2020 → present
-
JCO ConsultingLegal entityDirector· perm. rep.: Jean CombalbertState Gazette act 19107912 (08-08-2019)Current01-01-2019 → present
-
AJE ConsultingLegal entityDirector· perm. rep.: GODFROID EdmondState Gazette act 15132919 (18-09-2015)Current18-09-2015 → present
-
Current18-09-2015 → present
-
Life Sciences Research PartnersLegal entityDirector· perm. rep.: BUYSE ChrisState Gazette act 15132919 (18-09-2015)Current18-09-2015 → present
-
Current01-01-2014 → present
2 events
- 18-09-2015 Mandate renewed· Director
- 01-01-2014 Appointed· Director
-
JCO ConsultingLegal entityDirector· perm. rep.: COMBALBERT JeanState Gazette act 15132919 (18-09-2015)Current10-12-2013 → present
2 events
- 18-09-2015 Mandate renewed· Director
- 10-12-2013 Appointed· Director
-
SPRL AJE CONSULTINGLegal entityDirector· perm. rep.: Edmond GodfroidState Gazette act 14105977 (23-05-2014)Current10-12-2013 → present
2 events
- 10-12-2013 Appointed· Director
- 10-12-2013 Appointed· Managing director
-
CAPITAL & CROISSANCELegal entityDirector· perm. rep.: DETRIXHE PierreState Gazette act 15132919 (18-09-2015)Current10-07-2013 → present
2 events
- 18-09-2015 Mandate renewed· Director
- 10-07-2013 Appointed· Director
-
Current10-07-2013 → present
-
Current10-07-2013 → present
Former directors (8)
-
AJE CONSULTING SRLLegal entityDaily management· perm. rep.: Edmond GODFROIDState Gazette act 22130605 (04-11-2022)Former05-10-2022 → 16-12-2024
3 events
- 16-12-2024 Resigned· Director
- 16-12-2024 Resigned· Managing director
- 05-10-2022 Mandate renewed· Daily management
-
Former10-07-2013 → 01-01-2019
2 events
- 01-01-2019 Resigned· Director
- 10-07-2013 Appointed· Director
-
SPRL TCF ConsultingLegal entityDirector· perm. rep.: Oliver BoucherState Gazette act 15090815 (26-06-2015)Former— → 10-06-2015
-
SPRL TCF ConsuitingLegal entityDaily management· perm. rep.: Oliver BoucherState Gazette act 15048473 (02-04-2015)Former— → 21-01-2015
-
SPRL CARKATHLegal entityDirector· perm. rep.: Eric HaliouaState Gazette act 14143093 (24-07-2014)Former— → 01-01-2014
-
Former04-07-2013 → 10-12-2013
7 events
- 10-12-2013 Resigned· Director
- 10-12-2013 Resigned· Managing director
- 10-07-2013 Appointed· Managing director
- 10-07-2013 Mandate renewed· Director
- 04-07-2013 Appointed· Managing director
- 04-07-2013 Appointed· Director
- 04-07-2013 Resigned· Director
-
Former04-07-2013 → 10-07-2013
2 events
- 10-07-2013 Resigned· Director
- 04-07-2013 Appointed· Director
-
Former04-07-2013 → 10-07-2013
2 events
- 10-07-2013 Resigned· Director
- 04-07-2013 Appointed· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Didier DELANOYE |
— | 27-02-2025 → present |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
| NACE primary | 72101 |
| Legal form | Public limited company(014) |
| Incorporation | 20-04-2010 |
| Status | Active |
| Postal code | 6041 |
Connections & network
Group structure
Parent · 1 subsidiary · 1 location
Control→
Parent · 9 subsidiaries · 1 location
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 2 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Linked via shared directors
via Edmond GODFROID · Permanent representative
→
via HALIOUA Eric · Permanent representative
→
via Jean COMBALBERT · Permanent representative
→
Network connections
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units
BIOXODES
since 20102.187.055.535
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Updates
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
16-10-2025
State Gazette act
Director changes
16-10-2025
State Gazette act
Director changes
16-10-2025
State Gazette act
Director changes
16-07-2025
NBB filing
Annual accounts filed
01-07-2025
State Gazette act
Capital & shares
01-07-2025
State Gazette act
Capital & shares
01-07-2025
State Gazette act
Capital & shares
27-02-2025
State Gazette act
Director changes
27-02-2025
State Gazette act
Director changes
27-02-2025
State Gazette act
Director changes
2024
23-07-2024
NBB filing
Annual accounts filed
02-07-2024
State Gazette act
Capital & shares
02-07-2024
State Gazette act
Capital & shares
02-07-2024
State Gazette act
Capital & shares
11-01-2024
State Gazette act
Director changes
11-01-2024
State Gazette act
Capital & shares
11-01-2024
State Gazette act
Capital & shares
11-01-2024
State Gazette act
Director changes
11-01-2024
State Gazette act
Capital & shares
2023
31-10-2023
State Gazette act
Capital & shares
31-10-2023
State Gazette act
Capital & shares
31-10-2023
State Gazette act
Capital & shares
14-07-2023
NBB filing
Annual accounts filed
03-01-2023
State Gazette act
Capital & shares
03-01-2023
State Gazette act
Capital & shares
03-01-2023
State Gazette act
Capital & shares
2022
22-12-2022
State Gazette act
Director changes
22-12-2022
State Gazette act
Director changes
22-12-2022
State Gazette act
Director changes
04-11-2022
State Gazette act
Registered-office change
04-11-2022
State Gazette act
Director changes
04-11-2022
State Gazette act
Director changes
04-11-2022
State Gazette act
Registered-office change
23-08-2022
NBB filing
Annual accounts filed
2021
17-12-2021
State Gazette act
Capital & shares
17-12-2021
State Gazette act
Capital & shares
20-07-2021
State Gazette act
Capital & shares
20-07-2021
State Gazette act
Capital & shares
13-07-2021
NBB filing
Annual accounts filed
23-03-2021
State Gazette act
Director changes
23-03-2021
State Gazette act
Director changes
2020
04-08-2020
NBB filing
Annual accounts filed
17-07-2020
State Gazette act
Statutes amendment
17-07-2020
State Gazette act
Director changes
17-07-2020
State Gazette act
Director changes
17-07-2020
State Gazette act
Statutes amendment
2019
08-08-2019
State Gazette act
Director changes
08-08-2019
State Gazette act
Director changes
25-06-2019
NBB filing
Annual accounts filed
24-04-2019
State Gazette act
Capital & shares
24-04-2019
State Gazette act
Capital & shares
03-04-2019
State Gazette act
Capital & shares
03-04-2019
State Gazette act
Capital & shares
2018
31-07-2018
NBB filing
Annual accounts filed
2017
08-08-2017
NBB filing
Annual accounts filed
2016
30-06-2016
NBB filing
Annual accounts filed
2015
28-12-2015
State Gazette act
Capital & shares
28-12-2015
State Gazette act
Capital & shares
02-12-2015
State Gazette act
Capital & shares
02-12-2015
State Gazette act
Capital & shares
23-09-2015
State Gazette act
Capital & shares
23-09-2015
State Gazette act
Capital & shares
18-09-2015
State Gazette act
Director changes
18-09-2015
State Gazette act
Capital & shares
18-09-2015
State Gazette act
Director changes
18-09-2015
State Gazette act
Capital & shares
02-09-2015
State Gazette act
Capital & shares
02-09-2015
State Gazette act
Statutes amendment
02-09-2015
State Gazette act
Capital & shares
02-09-2015
State Gazette act
Statutes amendment
26-06-2015
State Gazette act
Director changes
26-06-2015
State Gazette act
Director changes
24-06-2015
State Gazette act
Miscellaneous
24-06-2015
State Gazette act
Capital & shares
24-06-2015
State Gazette act
Capital & shares
02-04-2015
State Gazette act
Director changes
2014
24-07-2014
State Gazette act
Director changes
18-07-2014
State Gazette act
Capital & shares
26-06-2014
State Gazette act
Capital & shares
23-05-2014
State Gazette act
Director changes
2013
10-07-2013
State Gazette act
Director changes
10-07-2013
State Gazette act
Statutes amendment
10-07-2013
State Gazette act
Capital & shares
10-07-2013
State Gazette act
Registered-office change
04-07-2013
State Gazette act
Statutes amendment
04-07-2013
State Gazette act
Capital & shares
04-07-2013
State Gazette act
Director changes
Belgisch Staatsblad — acts
Capital history · 39
01-07-2025
v3.2
01-07-2025
Capital change
01-07-2025
v3.2
02-07-2024
v3.2
02-07-2024
v3.2
02-07-2024
Capital change
11-01-2024
Capital change
11-01-2024
v3.2
11-01-2024
v3.2
31-10-2023
Capital change
31-10-2023
v3.2
31-10-2023
v3.2
03-01-2023
Capital change
03-01-2023
v3.2
03-01-2023
v3.2
Address history · 3
04-11-2022
v3.2
04-11-2022
Registered-office move
10-07-2013
v3.2
All acts · 77
updated 8 months ago
2025
16-10-2025 2 directors appointed
- SRL PHMBIO+ — Bestuurder
- SRL PHMBIO+ — Président du conseil d'administration
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SRL PHMBIO\u002B",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "SRL PHMBIO\u002B",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}16-10-2025 4 directors appointed
- Philippe MONTEYNE — Bestuurder
- Francine MESSINNE — Dagelijks bestuur
- Philippe MONTEYNE — Dagelijks bestuur
- Francine MESSINNE — Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-10-02",
"evidence_quote": "act\u00E9 la d\u00E9signation comme administrateur: la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 1
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "approuv\u00E9 la r\u00E9mun\u00E9ration de l\u0027administrateur pour son mandat de pr\u00E8sident du conseil d\u0027administration",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "mandat\u00E9 Me Francine MESSINNE, aux fins de d\u00E9p\u00F4t et de publication de ces d\u00E9cisions",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-10-02",
"evidence_quote": "d\u00E9sign\u00E8 la la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil a mandat\u00E9 Me Francine MESSINNE aux fins de d\u00E9p\u00F4t et de publication de ces d\u00E9cisions",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-10-16",
"filing_date": "2025-10-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-10-02",
"unanimous": null
},
{
"body": "raad_van_bestuur",
"date": "2025-10-02",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "mandataire sp\u00E9ciale"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}16-10-2025 Philippe MONTEYNE appointed as director
- Philippe MONTEYNE — Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0631922633",
"name": "SRL PHMBIO\u002B",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-10-02",
"evidence_quote": "act\u00E9 la d\u00E9signation comme administrateur: la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE, immatricul\u00E9e \u00E0 la BCE sous le n\u00BA BE0631.922.633 et ayant son si\u00E8ge All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau, pour une dur\u00E9e d\u0027un an avec effet imm\u00E9diat et jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9ral"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}01-07-2025 Capital decrease of €9,069,205.78 to €395,844.41
- €9.465.050,19 → €395.844,41
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 8398992.55,
"currency": "EUR",
"after_eur": 9465050.19,
"delta_eur": 8398992.55,
"before_eur": 1066057.64,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une augmentation de capital, sans cr\u00E9ation de titres, par incorporation des primes d\u2019\u00E9mission constitu\u00E9es lors de pr\u00E9c\u00E9dentes augmentations de capital, d\u0027un montant total de 8.398.992,55 \u20AC pour porter le capital temporairement de 1.066.057,64 \u20AC \u00E0 9.465. 050,19 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 9069205.78,
"currency": "EUR",
"after_eur": 395844.41,
"delta_eur": -9069205.78,
"before_eur": 9465050.19,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 9.069.205,78 \u20AC, sans annulation de titres, pour le ramener de 9.465. 050,19 \u20AC \u00E0 395.844,41 \u20AC, par apurement \u00E0 due concurrence de la perte report\u00E9e figurant \u00E0 la situation comptable arr\u00EAt\u00E9e au 31 d\u00E9cembre 2024.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}01-07-2025 Capital decrease of €9,069,205.78 to €395,844.41
- €9.465.050,19 → €395.844,41
- 2 kapitaalbewegingen in deze akte
Notary:
Simon Wets · Schaerbeek
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9465050.19,
"delta_eur": 8398992.55,
"before_eur": 1066057.64,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 395844.41,
"delta_eur": -9069205.78,
"before_eur": 9465050.19,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "loss_absorption",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-07-01",
"filing_date": "2025-06-27",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2025-06-26",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}01-07-2025 Capital increase of €8,398,992.55 to €9,465,050.19
- €1.066.057,64 → €9.465.050,19
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9465050.19,
"delta_eur": 8398992.549999999,
"before_eur": 1066057.64,
"contribution_type": "reserves_incorporation"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}27-02-2025 1 director appointed, 2 resigning
- Didier DELANOYE — Commissaris
- Edmond GODFROID — Bestuurder
- Edmond GODFROID — Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "d\u00E9sign\u00E9 la SRL PwC R\u00E9viseurs d\u0027Entreprises, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre ans, jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale charg\u00E9e d\u0027approuver les comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2017. Le repr\u00E9sentant permanent est M. Didier DELANOYE"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}27-02-2025 2 directors appointed, 1 resigning
- Didier DELANOYE — Commissaris
- Francine MESSINNE — Dagelijks bestuur
- Edmond GODFROID — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-12-16",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "4"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-02-27",
"filing_date": "2025-02-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-02-06",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "mandataire sp\u00E9ciale"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}27-02-2025 1 director appointed, 2 resigning
- SRL PwC Réviseurs d'Entreprises — Commissaire
- AJE CONSULTING SRL — Bestuurder
- AJE CONSULTING SRL — Dagelijks bestuur
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}2024
02-07-2024 Capital increase
- Inbreng in geld · Apport en numéraire
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}02-07-2024 Transaction in capital or shares
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}02-07-2024 Capital increase
- 4 kapitaalbewegingen in deze akte
Notary:
Simon Wets · Schaerbeek
Technical details
{
"events": [
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "ordinaire",
"n_new_shares": 493874,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3.484
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-07-02",
"filing_date": "2024-06-28",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2024-06-27",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP Petit \u0026 Co",
"ibr_number": null,
"mission_type": "fusion_special_report",
"individual_name": "Val\u00E9rie Denis"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Rapport sp\u00E9cial du conseil d\u2019administration",
"Rapport du R\u00E9viseur d\u0027Entreprises",
"Plans de Warrants"
],
"shareholders_after": [],
"share_classes_after": []
}11-01-2024 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}11-01-2024 Capital increase of €2,456.50 to €1,066,057.64
- €1.063.601,14 → €1.066.057,64
- Inbreng in geld · Apport en numéraire
Notary:
Simon Wets · Schaerbeek
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"share_emission": {
"agio_eur": 41760.5,
"share_form": "pair_comptable",
"share_class": "ordinaires",
"n_new_shares": 24565,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.7
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 2456.5,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "privil\u00E9gi\u00E9es",
"n_new_shares": 7361931,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-01-11",
"filing_date": "2024-01-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-01-08",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-01-05"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 8001496,
"class_name": "ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 7361931,
"class_name": "privil\u00E9gi\u00E9es",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}11-01-2024 Capital increase of €2,456.50 to €1,066,057.64
- €1.063.601,14 → €1.066.057,64
- Inbreng in geld · Apport en numéraire
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}11-01-2024 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}11-01-2024 Capital increase of €2,456.50 to €1,066,057.64
- €1.063.601,14 → €1.066.057,64
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2456.5,
"currency": "EUR",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-01-08",
"evidence_quote": "L\u0027administrateur pr\u00E9cit\u00E9 constate l\u0027augmentation de capital de 2.456,50 \u20AC pour le porter de 1.063.601,14 \u20AC \u00E0 1.066.057,64 \u20AC par la cr\u00E9ation de 24.565 actions ordinaires nouvelles... Les actions nouvelles ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2023
31-10-2023 Capital increase of €372,938.70 to €1,063,601.14
- €690.662,44 → €1.063.601,14
- 3 kapitaalbewegingen in deze akte
Notary:
Simon Wets · SchaerbeekFirm:
Benjamin Wets & Simon Wets, notaires associés
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"share_emission": {
"agio_eur": 3642265.67,
"share_form": "no_nominal_value",
"share_class": "privil\u00E9gi\u00E9es",
"n_new_shares": 1070307,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3.484409
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": "Benjamin Wets \u0026 Simon Wets, notaires associ\u00E9s",
"office_city": "Schaerbeek",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-10-31",
"filing_date": "2023-10-27",
"act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-10-26",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP Petit \u0026 Co",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Val\u00E9rie Denis"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"rapport sp\u00E9cial du Conseil d\u2019administration",
"rapport dress\u00E9 par le Reviseur d\u0027Entreprises",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 615000,
"class_name": "ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 7361931,
"class_name": "privil\u00E9gi\u00E9es",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}31-10-2023 Capital increase of €372,938.70 to €1,063,601.14
- €690.662,44 → €1.063.601,14
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 372938.7,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 372.938,70 \u20AC, pour le porter de 690.662,44 \u00E0 1.063.601,14 \u20AC",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 1200000,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide de renouveler l\u2019autorisation... d\u2019augmenter le capital \u00E0 concurrence d\u2019un maximum de 1.200.000 \u20AC",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}31-10-2023 Capital increase of €372,938.70 to €1,063,601.14
- €690.662,44 → €1.063.601,14
- Inbreng in natura · Apport en nature
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1063601.14,
"delta_eur": 372938.69999999995,
"before_eur": 690662.44,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}03-01-2023 Capital increase of €8,561,218.28 to €9,251,880.72
- €690.662,44 → €9.251.880,72
- 2 kapitaalbewegingen in deze akte
Notary:
Benjamin Wets · SchaerbeekFirm:
Benjamin Wets & Simon Wets, notaires associés
Technical details
{
"events": [
{
"kind": "agio_incorporation",
"after_eur": 9251880.72,
"delta_eur": 8561218.28,
"before_eur": 690662.44,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "capital_decrease",
"after_eur": 690662.44,
"delta_eur": -8561218.28,
"before_eur": 9251880.72,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Benjamin Wets",
"firm_city": null,
"firm_name": "Benjamin Wets \u0026 Simon Wets, notaires associ\u00E9s",
"office_city": "Schaerbeek",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-01-03",
"filing_date": "2022-12-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-12-29",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}03-01-2023 Capital increase of €8,561,218.28 to €9,251,880.72
- €690.662,44 → €9.251.880,72
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9251880.72,
"delta_eur": 8561218.280000001,
"before_eur": 690662.44,
"contribution_type": "reserves_incorporation"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}03-01-2023 Capital increase of €8,561,218.28 to €9,251,880.72
- €690.662,44 → €9.251.880,72
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 9251880.72,
"delta_eur": 8561218.28,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide donc d\u0027augmenter temporairement le capital \u00E0 concurrence de 8.561.218,28 \u20AC pour le porter de 690.662,44 \u20AC \u00E0 9.251.880,72 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 690662.44,
"delta_eur": -8561218.28,
"before_eur": 9251880.72,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 8.561.218,28 \u20AC, sans annulation de titres, pour le ramener de 9.251.880,72 \u20AC \u00E0 690.662,44 \u20AC",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}2022
22-12-2022 Marc DECHAMPS appointed as director
- Marc DECHAMPS — Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0659744114",
"name": "SRL XMF",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-11-08",
"evidence_quote": "La SRL XMF, d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (immatricul\u00E9e \u00E0 la BCE sous le n\u00B00659.744.114 et dont le si\u00E8ge est situ\u00E9 Avenue Louis David 68 \u00E0 1410 Waterioo, Belgique), ayant pour repr\u00E9sentant permanent Monsieur Marc DECHAMPS, est nomm\u00E9e administrateur de Bioxodes"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}22-12-2022 3 directors appointed
- Marc DECHAMPS — Bestuurder
- XMF — Gedelegeerd bestuurder
- AJE Consulting — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": "0659.744.114",
"name": "SRL XMF",
"address": "Avenue Louis David 68, 1410 Waterloo",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "La SRL XMF, d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (immatricul\u00E9e \u00E0 la BCE sous le n\u00B00659.744.114 et dont le si\u00E8ge est situ\u00E9 Avenue Louis David 68 \u00E0 1410 Waterioo, Belgique), ayant pour repr\u00E9sentant permanent Monsieur Marc DECHAMPS, est nomm\u00E9e administrateur de Bioxodes",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "XMF",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "XMF en AJE Consulting zullen co-administrators d\u00E9l\u00E9gu\u00E9s zijn met concurrente beslissings- en vertegenwoordigingsbevoegdheden.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "AJE Consulting",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "XMF en AJE Consulting zullen co-administrators d\u00E9l\u00E9gu\u00E9s zijn met concurrente beslissings- en vertegenwoordigingsbevoegdheden.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-12-22",
"filing_date": "2022-12-12",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2022-11-08",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "avocate et mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}22-12-2022 2 directors appointed
- XMF — Bestuurder
- Marc DECHAMPS — Représentant permanent
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "XMF",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}04-11-2022 Registered office moved from Marche-en-Famenne to Gosselies
- rue de la Plaine 11, 6900 Marche-en-Famenne → Santos Dumont 1, 6041 Gosselies
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gosselies",
"region": "Waals",
"street": "Santos Dumont",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "1"
},
"old_address": {
"city": "Marche-en-Famenne",
"region": "Waals",
"street": "rue de la Plaine",
"country": "BE",
"postcode": "6900",
"box_number": null,
"street_number": "11"
},
"effective_date": "2022-10-14",
"evidence_quote": "Le si\u00E8ge social est transf\u00E9r\u00E9 rue Santos Dumont 1 \u00E0 6041 Gosselies avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}04-11-2022 3 directors appointed, 2 resigning
- SRL XMF — Délégué à la gestion journalière et ceo
- AJE CONSULTING SRL — Chief operating officer et chief scientific officer
- rue Santos Dumont 1, 6041 Gosselies — Nouveau siège social
- siège social — Siège social
- rue de la Plaine 11, 6900 Marche-en-Famenne — Ancien siège social
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re et CEO",
"person": {
"rrn": null,
"name": "SRL XMF",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Operating Officer et Chief Scientific Officer",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "si\u00E8ge social",
"person": {
"rrn": null,
"name": "si\u00E8ge social",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "ancien si\u00E8ge social",
"person": {
"rrn": null,
"name": "rue de la Plaine 11, 6900 Marche-en-Famenne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "nouveau si\u00E8ge social",
"person": {
"rrn": null,
"name": "rue Santos Dumont 1, 6041 Gosselies",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}04-11-2022 2 reappointed
- Marc Dechamps — Dagelijks bestuur
- Edmond Godfroid — Dagelijks bestuur
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Marc Dechamps",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0659744114",
"name": "SRL XMF",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Confirmation de la nomination de la SRL XMF, ayant pour repr\u00E9sentant permanent Mr Marc Dechamps, comme d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re et CEO, \u00E0 dater du 5 octobre 2022 et pour une dur\u00E9e ind\u00E9termin\u00E9e."
},
{
"kind": "director_renew",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Edmond Godfroid",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Confirmation de la nomination de AJE CONSULTING SRL, ayant pour repr\u00E9szentant permanent Edmond Godfroid, comme Chief Operating Officer et Chief Scientific Officer avec effet au 5 octobre 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}04-11-2022 Registered office moved from Marche-en-Famenne to Gosselies
- Parc d'activités économiques du WEX, rue de la Plaine 11, 6900 Marche-en-Famenne → rue Santos Dumont 1 à 6041 Gosselies
Notary:
Francine MESSINNE · Liège
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue Santos Dumont 1 \u00E0 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "rue Santos Dumont",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "1",
"locality_suffix": null
},
"old_address": {
"raw": "Parc d\u0027activit\u00E9s \u00E9conomiques du WEX, rue de la Plaine 11, 6900 Marche-en-Famenne",
"city": "Marche-en-Famenne",
"region": "waals_gewest",
"street": "rue de la Plaine",
"country": "BE",
"postcode": "6900",
"box_number": null,
"street_number": "11",
"locality_suffix": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Le si\u00E8ge social est transf\u00E9r\u00E9 rue Santos Dumont 1 \u00E0 6041 Gosselies avec effet imm\u00E9diat.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Francine MESSINNE",
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-11-04",
"filing_date": "2022-10-14",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2022-10-14",
"unanimous": true
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "avocate et mandataire"
},
"co_filed_documents": [
"Acte notari\u00E9",
"D\u00E9p\u00F4t au greffe du Tribunal de l\u0027entreprise de Li\u00E8ge division Marche-en-Famenne"
]
}First 30 of 77 acts
Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE)
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | BIOXODES |
Registered office
Rue Santos - Dumont 1
6041 Charleroi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
CANCER STATE THERAPEUTICS
BE 0793.113.273 · Charleroi
Aboleris Holdco
BE 0803.217.012 · Charleroi
CellCarta Biosciences
BE 0661.567.021 · Charleroi
ConvEyXo
BE 0725.874.259 · Charleroi
DNAVision
BE 0865.300.475 · Charleroi